Core Viewpoint - The company, Hema Medical (03309.HK), announced the acquisition of 58% of the issued share capital of Hong Kong Endoscopy Centre Limited, which will become a subsidiary upon completion of the transaction expected around October 2025 [1] Group 1: Acquisition Details - The acquisition agreement was signed with three individual sellers [1] - Hong Kong Endoscopy Centre, established in 2016, operates three endoscopy examination rooms and provides specialized medical services including gastroscopy, colonoscopy, and cystoscopy [1] - The acquisition aims to enhance the company's medical services in Hong Kong and leverage existing patient bases for synergistic effects with its operations in Hong Kong and cross-border business in Shenzhen [1] Group 2: Market Position and Strategy - The company has been actively seeking to expand its market opportunities to meet the demand for high-quality medical services [1] - Hong Kong Endoscopy Centre has a strong reputation in Hong Kong, with advantages in management, quality medical services, and financial performance [1]